Loss of heterozygosity (LOH) of chromosomal regions bearing tumor suppressors is a key event in the evolution of epithelial and mesenchymal tumors. Identification of these regions usually relies on genotyping tumor and counterpart normal DNA and noting regions where heterozygous alleles in the normal DNA become homozygous in the tumor. However, paired normal samples for tumors and cell lines are often not available. With the advent of oligonucleotide arrays that simultaneously assay thousands of single-nucleotide polymorphism (SNP) markers, genotyping can now be done at high enough resolution to allow identification of LOH events by the absence of heterozygous loci, without comparison to normal controls. Here we describe a hidden Markov mod...
Loss of heterozygosity (LOH), either with or without accompanying copy-number loss, is a cardinal fe...
Novel technologies, such as the 10k Affymetrix genotyping array, allow scoring of genetic polymorph...
Tumor samples obtained from a single cancer patient spatially or temporally often consist of varying...
Loss of heterozygosity (LOH) of chromosomal regions bearing tumor suppressors is a key event in the ...
Identifying regions of loss-of-heterozygosity (LOH) in a tumor sample is a challenging problem. Stat...
Background Loss of heterozygosity (LOH) is an important marker for one of the 'two-hits' required fo...
Genetic heterogeneity in a mixed sample of tumor and normal DNA can confound characterization of the...
Background: Single nucleotide polymorphisms (SNPs) are the most common genetic variations in the hum...
The aim of this study was assessment of possible effects of loss of heterozygosity on human genetic ...
Detection of DNA aberrations in a tumor sample is often complicated by the contamination of DNA from...
Loss of heterozygosity (LOH) is a common genetic lesion found in many human neoplasms. Extending inv...
The Knudson "two-hit" hypothesis has provided the rationale for studies that aim to identify tumor-s...
Genomic aberrations such as copy number alterations (CNA) and loss of heterozygosity (LOH) are hallm...
g.oxfordjournals.org/ D ow nloaded from 2 Identifying regions of loss-of-heterozygosity (LOH) in a t...
Loss of heterozygosity (LOH) is a common genetic event in cancer development, and is known to be inv...
Loss of heterozygosity (LOH), either with or without accompanying copy-number loss, is a cardinal fe...
Novel technologies, such as the 10k Affymetrix genotyping array, allow scoring of genetic polymorph...
Tumor samples obtained from a single cancer patient spatially or temporally often consist of varying...
Loss of heterozygosity (LOH) of chromosomal regions bearing tumor suppressors is a key event in the ...
Identifying regions of loss-of-heterozygosity (LOH) in a tumor sample is a challenging problem. Stat...
Background Loss of heterozygosity (LOH) is an important marker for one of the 'two-hits' required fo...
Genetic heterogeneity in a mixed sample of tumor and normal DNA can confound characterization of the...
Background: Single nucleotide polymorphisms (SNPs) are the most common genetic variations in the hum...
The aim of this study was assessment of possible effects of loss of heterozygosity on human genetic ...
Detection of DNA aberrations in a tumor sample is often complicated by the contamination of DNA from...
Loss of heterozygosity (LOH) is a common genetic lesion found in many human neoplasms. Extending inv...
The Knudson "two-hit" hypothesis has provided the rationale for studies that aim to identify tumor-s...
Genomic aberrations such as copy number alterations (CNA) and loss of heterozygosity (LOH) are hallm...
g.oxfordjournals.org/ D ow nloaded from 2 Identifying regions of loss-of-heterozygosity (LOH) in a t...
Loss of heterozygosity (LOH) is a common genetic event in cancer development, and is known to be inv...
Loss of heterozygosity (LOH), either with or without accompanying copy-number loss, is a cardinal fe...
Novel technologies, such as the 10k Affymetrix genotyping array, allow scoring of genetic polymorph...
Tumor samples obtained from a single cancer patient spatially or temporally often consist of varying...